TY - JOUR
T1 - The GABAA receptor agonist THIP is neuroprotective in organotypic hippocampal slice cultures
AU - Kristensen, Bjarne W
AU - Noraberg, Jens
AU - Zimmer, Jens
PY - 2003/5/30
Y1 - 2003/5/30
N2 - The potential neuroprotective effects of the GABA(A) receptor agonists THIP (4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol) and muscimol, and the selective GluR5 kainate receptor agonist ATPA ((RS)-2-amino-3-(3-hydroxy-5-tert-butylisoxazol-4-yl)propanoic acid), which activates GABAergic interneurons, were examined in hippocampal slice cultures exposed to N-methyl-D-aspartate (NMDA). The NMDA-induced excitotoxicity was quantified by densitometric measurements of propidium iodide (PI) uptake. THIP (100-1000 microM) was neuroprotective in slice cultures co-exposed to NMDA (10 microM) for 48 h, while muscimol (100-1000 microM) and ATPA (1-3 microM) were without effect. The results demonstrate that direct GABA(A) agonism can mediate neuroprotection in the hippocampus in vitro as previously suggested in vivo.
AB - The potential neuroprotective effects of the GABA(A) receptor agonists THIP (4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol) and muscimol, and the selective GluR5 kainate receptor agonist ATPA ((RS)-2-amino-3-(3-hydroxy-5-tert-butylisoxazol-4-yl)propanoic acid), which activates GABAergic interneurons, were examined in hippocampal slice cultures exposed to N-methyl-D-aspartate (NMDA). The NMDA-induced excitotoxicity was quantified by densitometric measurements of propidium iodide (PI) uptake. THIP (100-1000 microM) was neuroprotective in slice cultures co-exposed to NMDA (10 microM) for 48 h, while muscimol (100-1000 microM) and ATPA (1-3 microM) were without effect. The results demonstrate that direct GABA(A) agonism can mediate neuroprotection in the hippocampus in vitro as previously suggested in vivo.
KW - Analysis of Variance
KW - Animals
KW - Animals, Newborn
KW - Cell Death/drug effects
KW - Dose-Response Relationship, Drug
KW - Glutamate Decarboxylase/metabolism
KW - Hippocampus/drug effects
KW - Isoxazoles/pharmacology
KW - Kainic Acid/adverse effects
KW - Muscimol/pharmacology
KW - N-Methylaspartate/adverse effects
KW - Neuroprotective Agents/pharmacology
KW - Organ Culture Techniques
KW - Propidium/metabolism
KW - Pyramidal Cells/drug effects
KW - Rats
KW - Rats, Wistar
KW - Time Factors
KW - alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid/pharmacology
U2 - 10.1016/s0006-8993(03)02550-2
DO - 10.1016/s0006-8993(03)02550-2
M3 - Journal article
C2 - 12738075
SN - 0006-8993
VL - 973
SP - 303
EP - 306
JO - Brain Research
JF - Brain Research
IS - 2
ER -